View Older Stories

Sep 30, 2026 06:01AM Moderna (MRNA) call put ratio 1.4 calls to 1 put into share price lower before the bell

Sep 30, 2026 05:03AM Citi downgrades Moderna to Sell, sets $80 price target

Sep 25, 2026 08:09AM Bernstein SocGen Reiterates Market Perform Rating on Moderna (MRNA)

Sep 22, 2026 09:25AM UBS Reiterates Neutral Rating on Moderna (MRNA)

Sep 21, 2026 10:13AM Moderna to present mRNA cancer therapy data at ESMO 2026

Sep 21, 2026 10:12AM Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026

Sep 21, 2026 10:06AM Moderna shares climb on cancer vaccine momentum

Sep 17, 2026 10:30AM Moderna (MRNA) spreader of 1K contracts of September 25 weekly 157.50 and 165 calls as share price up 10.5%

Sep 17, 2026 10:10AM Moderna shares gain on momentum and short squeeze

Sep 3, 2026 02:31AM Rothschild Redburn Downgrades Moderna (MRNA) to Sell

Sep 1, 2026 09:07AM Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'

Sep 1, 2026 07:00AM Moderna to Present at Upcoming Conferences in September 2026

Aug 28, 2026 07:30AM Argus Upgrades Moderna (MRNA) to Buy

Aug 28, 2026 07:00AM Moderna prices $2.6B convertible notes offering due 2032

Aug 28, 2026 07:00AM Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Aug 27, 2026 03:58PM FDA approves Moderna's updated 2026-2027 COVID-19 vaccines

Aug 27, 2026 03:56PM Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines

Aug 27, 2026 07:21AM Moderna plans $2B convertible notes offering due 2032

Aug 27, 2026 07:20AM Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes

Aug 25, 2026 05:32AM Wolfe Research Upgrades Moderna (MRNA) to Peerperform

Aug 24, 2026 05:25AM Active options: MRNA SOFI BABA INTC MARA META COIN AMD GOOGL MSFT WMT

Aug 24, 2026 05:21AM Moderna (MRNA) call put ratio 1.1 calls to 1 put amid sharp rally

Aug 20, 2026 07:23AM Moderna stock pulls back after massive one-day rally: analysts weigh in

Aug 20, 2026 06:47AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Aug 20, 2026 04:51AM Moderna (MRNA) call put ratio 1 calls to 2.1 puts amid wide price movement

Aug 19, 2026 04:23PM Moderna (MRNA) PT Raised to $89 at Morgan Stanley

Aug 19, 2026 04:22PM Morgan Stanley Upgrades Merck (MRK) to Overweight

Aug 19, 2026 03:11PM Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN

Aug 19, 2026 01:40PM BofA Securities Upgrades Moderna (MRNA) to Neutral

Aug 19, 2026 11:31AM Moderna short sellers face $4.8 billion loss amid record stock jump

Aug 19, 2026 11:21AM Moderna (MRNA) call put ratio 1 calls to 1.9 puts after INTerpath-001 trial results

Aug 19, 2026 09:34AM Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA) Following Positive Intismeran Data

Aug 19, 2026 09:18AM Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY

Aug 19, 2026 09:11AM Moderna (MRNA) call put ratio 2.1 calls to 1 put into INTerpath-001 trial results

Aug 19, 2026 08:11AM William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business

Aug 19, 2026 07:03AM Moderna shares soar on melanoma drug trial success

Aug 6, 2026 04:36PM Trump Administration Weighs Order On Autism And Vaccines - Bloomberg

Aug 6, 2026 08:42AM Piper Sandler Reiterates Overweight Rating on Moderna (MRNA) Following FDA Approval of mRNA Flu Vaccine

Aug 5, 2026 10:15PM FDA approves Moderna's mRNA influenza vaccine for adults 50 and older

Aug 5, 2026 10:15PM Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

Aug 4, 2026 11:01AM Moderna begins Phase 1 trial of Bundibugyo ebolavirus vaccine

Aug 4, 2026 11:00AM Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

Aug 3, 2026 10:05AM Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)

Aug 1, 2026 10:00AM U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage

Jul 31, 2026 07:01AM Moderna (MRNA) Tops Q2 EPS by 6c, Beats on Revenue

Jul 31, 2026 07:00AM Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Jul 20, 2026 05:34AM Moderna (MRNA) PT Raised to $25 at Wolfe Research

Jul 16, 2026 07:01AM Moderna doses first patient in Phase 1 trial for mRNA-4200 cancer therapy

Jul 16, 2026 07:00AM Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

Jul 10, 2026 11:12AM JPMorgan analysts name top short ideas for third quarter 2026

View Older Stories